Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial
Ana Oaknin, Bradley J. Monk, Andréia Cristina de Melo, Hee Seung Kim, Yong Man Kim, Alla S. Lisyanskaya, Vanessa Samouëlian, Domenica Lorusso, Fernanda Damian, Chih‐Long Chang, Evgeniy Gotovkin, Shunji Takahashi, Daniella Ramone, Beata Maćkowiak-Matejczyk, Laura Polastro, Eva María Guerra Alia, Nicoletta Colombo, Yulia Makarova, Jeffrey C. Goh, Kosei Hasegawa, Paulo Mora, Joanna Pikiel, Ratnesh Kumar Srivastav, Danny Rischin, María Jesús Rubio, Javier J. Pérez, Suk Young Yoo, Bo Gao, Shaheda Jamil, Frank Seebach, Israel Lowy, Melissa Mathias, Matthew G. Fury, Krishnansu S. Tewari
Topics & Concepts
Cervical cancerMedicinePhase (matter)OncologyInternal medicineCancerPhysicsQuantum mechanicsEndometrial and Cervical Cancer TreatmentsCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses